Tiny white bumps on your face can be frustrating, but understanding their cause is key to effective treatment. Milia, closed ...

Needham analyst Ami Fadia upgraded Neurocrine (NBIX) to Buy from Hold with a $138 price target The firm cites its positive physician survey on ...

A new research paper was published in Oncotarget, Volume 16, on April 4, 2025, titled “Association between two single ...

A medical team at Charles-Nicolle University Hospital successfully performed three high-precision procedures on Sunday to ...

Maintaining prostate health is essential for men’s overall well-being, particularly as they age. The prostate gland plays a ...

Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing ...

Get to Know What Endometrial Hyperplasia Is? Endometrial hyperplasia refers to the thickening of the endometrium, or the ...

Jefferies downgraded EDAP TMS (EDAP) to Hold from Buy with a price target of $2, down from $8. The firm sees downside to consensus estimates.

Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.

This scoping review examines the impact of Rezum therapy on sexual function in patients with benign prostatic hyperplasia (BPH). Analyzing 15 studies with 2,425 patients, the review finds that Rezum ...

UVA Health Culpeper Medical Center’s “aquablation” procedure can offer relief for men.